BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36358811)

  • 1. Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Ramírez-Tortosa CL; Alonso-Calderón R; Gálvez-Navas JM; Pérez-Ramírez C; Quiles JL; Sánchez-Rovira P; Jiménez-Morales A; Ramírez-Tortosa M
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer.
    Nie C; Lv H; Bie L; Hou H; Chen X
    Medicine (Baltimore); 2018 Dec; 97(51):e13551. PubMed ID: 30572455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
    Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
    Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
    Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
    Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
    Yamamoto Y; Ibusuki M; Okumura Y; Kawasoe T; Kai K; Iyama K; Iwase H
    Breast Cancer Res Treat; 2008 Aug; 110(3):465-75. PubMed ID: 17805961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
    Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
    Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
    Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
    BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Zhang J; Zhang S; Gao S; Ma Y; Tan X; Kang Y; Ren W
    Cancer Manag Res; 2020; 12():2209-2222. PubMed ID: 32273760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation analysis of HIF-1α and Ca15-3 in response to neoadjuvant chemotherapy in locally advanced breast cancer: A cohort study in Indonesia.
    Manginstar C; Oley MH; Oley MC; Merung M; Langi FLFG; Kepel BJ; Rusli LV; Islam AA; Faruk M
    Breast Dis; 2022; 41(1):481-487. PubMed ID: 36641657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
    Li JN; Feng ZE; Wang L; Wang YX; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
    Yin X; Xia J; Sun Y; Zhang Z
    BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
    Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
    Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical research on the expression of three vascular regulatory factors in different morphological regions of Marjolin ulcer and their relationship with angiogenesis].
    Xia C; Chu ZG
    Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):676-682. PubMed ID: 31594186
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Hypoxia-inducible factor 1-α and vascular endothelial growth factor-C in locally advanced breast cancer patients.
    Brito LG; Schiavon VF; Andrade JM; Tiezzi DG; Peria FM; Marana HR
    Clinics (Sao Paulo); 2011; 66(8):1313-20. PubMed ID: 21915477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
    Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
    Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.